Rosai-Dorfman病中枢神经系统受累的磁共振成像:单中心经验及文献综述
本文通过单中心病例结合文献综述,总结Rosai-Dorfman病(RDD)的中枢神经系统受累(CNS-RDD)的MRI特征,指出脑部受累仅约5%,常表现为硬脑膜病变,MRI是检测CNS病变的一线策略,并可能为鉴别诊断提供额外信息,同时综述了手术与药物治疗进展。
要点
- RDD脑部受累仅约5%,多表现为硬脑膜基于的病变,MRI为CNS病变检测的一线手段。
- MRI可为CNS-RDD与其他常见病变的鉴别诊断提供额外影像要素。
- 组织病理学是最终诊断的关键,但影像学在CNS受累检出中起重要作用。
核心结论
- 脑部受累仅约5%,通常表现为硬脑膜基于的病变,MRI是检测CNS病变的一线策略,并可能为鉴别诊断提供额外要素。
研究设计与样本
- 单中心病例结合文献综述,纳入本中心病例并回顾文献,聚焦CNS-RDD的MRI特征。
关键影像表现/征象
- CNS-RDD通常表现为硬脑膜基于的病变。
- RDD常见特征为无痛、无压痛、双侧颈部巨大淋巴结病。
诊断标准与关键数值
- 脑部受累仅约5%的病例,结外受累通常见于50%的患者。
临床应用与阅片要点
- MRI目前是检测中枢神经系统病变的一线策略。
- MRI可能为CNS-RDD与其他更常见病变的鉴别诊断提供额外要素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Rosai-Dorfman disease (RDD) is a rare, benign, non-Langerhans cells histiocytosis with massive lymphadenopathy of uncertain aetiology. It is commonly characterized by massive, painless, non-tender, bilateral cervical lymphadenopathy. Extra-nodal involvement is usually seen in 50% of patients, with the brain being affected in only 5% of cases, usually as dural-based lesions. Clinical presentation is heterogeneous and strongly dependent on the localization of the lesions. Although the histopathological findings are essential for the final diagnosis, brain magnetic resonance imaging (MRI) currently represents the first-line strategy for the detection of the lesions across the central nervous system (CNS); moreover, it may provide additional elements for the differential diagnosis versus other more common lesions. We performed a case-based literature review to highlight possible aetiologic and pathogenetic theories of this disease, along with imaging features of RDD, with a particular focus on the MRI characteristics of the CNS involvement (CNS-RDD). Finally, we provided a novel insight on the current therapeutic approaches, either surgical or medical.
引用
- Varrassi M, Corridore A, Tommasino E, et al. MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature. Radiol Med. 2020. PMID: 32458270. doi:10.1007/s11547-020-01226-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。